Currently, numerous studies have established that the expression of PLOD1 and PLOD2 is elevated in CRC and that these genes could serve as potential biomarkers [13, 14], suggesting that PLOD3, the only isozyme responsible for collagen synthesis and maturation [15], might also play a significant role in the progression of CRC. The gene discussed is PLOD3; the disease is colorectal carcinoma.